Johnson & Johnson (JNJ) Receives CE Mark for New Contact Lens
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowJohnson & Johnson (JNJ) has received the CE mark for its new contact lenses that are designed to be worn for two weeks. This regulatory approval allows the company to market the product in European countries. The CE mark is a significant milestone as it indicates compliance with safety, health, and environmental protection standards within the European Economic Area. The introduction of new products like these can enhance JNJ's portfolio and potentially boost revenues from the contact lens segment.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Johnson & Johnson (JNJ)
Johnson & Johnson is a healthcare giant spanning pharmaceuticals and medical devices, known for its deep drug pipeline.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier JNJ news
- J&J (JNJ) Continues Climb as Key Drivers Support Record Highs
- Johnson & Johnson (JNJ) Named Top Dividend Stock to Buy Now
- Johnson & Johnson Signals Strong Dividend Stock Potential
- Johnson & Johnson (JNJ) Dividend Growth Strategy for $79,200 Income
- Johnson & Johnson (JNJ) EVP sells $3.95 million in stock
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
